dr. reddy's labs glp-1 receptor agonist medications With the launch of Obeda®, India's first DCGI-approved semaglutide injection for Type 2 Diabetes, we are excited to support diabetes care in India with high-quality, accessible and affordable treatment. In a head-to-head Dr. Reddy's Laboratories Launches Obeda:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14








:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)




:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)













![Shellder (19/83) [XY: Generations] 094](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/ca2cb219-2427-453a-b9a8-8721a089b1db_37e50b62-f538-4416-88ee-6acf58522024.png?v=1696337300)
![Zubat (30/83) [XY: Generations] Item](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/9c0f39d4-7e22-4476-b4e8-72c7841dab5a_3d6969b4-fd6e-497b-ab35-0f220d09304b.png?v=1696337300)